DEL BELLO, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.816
EU - Europa 7.074
AS - Asia 6.186
SA - Sud America 724
Continente sconosciuto - Info sul continente non disponibili 566
AF - Africa 253
OC - Oceania 52
Totale 29.671
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.341
CN - Cina 2.380
SG - Singapore 1.816
IT - Italia 1.637
RU - Federazione Russa 1.532
DE - Germania 939
PL - Polonia 712
BR - Brasile 585
VN - Vietnam 535
HK - Hong Kong 503
GB - Regno Unito 383
CA - Canada 370
UA - Ucraina 368
FR - Francia 357
SE - Svezia 320
FI - Finlandia 311
ZA - Sudafrica 175
TR - Turchia 170
KR - Corea 154
IN - India 146
IE - Irlanda 115
BD - Bangladesh 106
JP - Giappone 89
CZ - Repubblica Ceca 82
NL - Olanda 68
MX - Messico 66
BE - Belgio 60
PK - Pakistan 52
AR - Argentina 51
AU - Australia 49
ES - Italia 48
EU - Europa 38
IQ - Iraq 35
IR - Iran 32
EG - Egitto 28
AT - Austria 23
ID - Indonesia 21
EC - Ecuador 20
MY - Malesia 20
SA - Arabia Saudita 17
UY - Uruguay 15
HR - Croazia 14
PT - Portogallo 14
CO - Colombia 13
LT - Lituania 13
PE - Perù 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 11
RO - Romania 11
TW - Taiwan 11
KE - Kenya 10
NP - Nepal 10
PH - Filippine 10
BY - Bielorussia 9
HU - Ungheria 9
CH - Svizzera 8
CL - Cile 8
GR - Grecia 8
MA - Marocco 8
UZ - Uzbekistan 8
HN - Honduras 7
JM - Giamaica 7
AL - Albania 6
AZ - Azerbaigian 6
KG - Kirghizistan 6
PS - Palestinian Territory 6
RS - Serbia 6
TH - Thailandia 6
TN - Tunisia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
DK - Danimarca 5
DZ - Algeria 5
IL - Israele 5
JO - Giordania 5
LV - Lettonia 5
PY - Paraguay 5
TT - Trinidad e Tobago 5
KH - Cambogia 4
QA - Qatar 4
SN - Senegal 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GT - Guatemala 3
LK - Sri Lanka 3
NG - Nigeria 3
NI - Nicaragua 3
OM - Oman 3
PA - Panama 3
BG - Bulgaria 2
BO - Bolivia 2
BS - Bahamas 2
ET - Etiopia 2
GA - Gabon 2
GH - Ghana 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
Totale 29.125
Salva come PNG Salva come JPEG
Città #
Dallas 1.318
Ashburn 1.114
Singapore 954
Fairfield 925
Jacksonville 867
Woodbridge 819
San Jose 718
Chandler 602
Warsaw 579
Council Bluffs 543
Houston 526
Ann Arbor 518
Hong Kong 482
Wilmington 459
Boardman 426
Beijing 416
Seattle 373
Camerino 353
Cambridge 293
Nanjing 275
Los Angeles 242
New York 242
Toronto 236
Dearborn 203
Ho Chi Minh City 176
Helsinki 166
Johannesburg 158
The Dalles 157
Seoul 144
San Mateo 140
Tongling 139
Lawrence 130
Princeton 129
Santa Clara 124
Istanbul 123
Hanoi 122
Lauterbourg 122
Dublin 116
Kraków 113
Columbus 111
Munich 111
Nanchang 104
Orem 103
Ogden 96
Moscow 95
Buffalo 94
London 94
Düsseldorf 93
Milan 90
Shanghai 77
Tokyo 69
Shenyang 67
Guangzhou 64
São Paulo 60
Jiaxing 57
Kunming 57
Rome 57
Brno 56
Chicago 55
Brussels 52
Frankfurt am Main 51
Trieste 51
Lachine 50
Jinan 49
Phoenix 49
Tianjin 48
Turku 47
Chennai 46
San Diego 46
Changsha 41
Manchester 41
Hebei 39
Bremen 38
Centro 36
Philadelphia 36
St Louis 36
Brooklyn 34
Montreal 34
Denver 33
Hangzhou 33
Zhengzhou 33
Ascoli Piceno 30
Mexico City 30
Stockholm 30
Dong Ket 29
Redondo Beach 29
Wuhan 29
Da Nang 27
Poplar 27
Redwood City 27
Atlanta 26
Nuremberg 25
Perugia 25
Venezia 25
Ningbo 24
Amsterdam 23
Haiphong 23
Hefei 22
Leawood 21
Mumbai 21
Totale 18.568
Salva come PNG Salva come JPEG
Nome #
1,4-Dioxane nucleus as a suitable scaffold in the building of ligands interacting with NMDA and σ1 receptors 655
1,4-DIOXANE NUCLEUS AS A SUITABLE SCAFFOLD FOR NOVEL D2-LIKE RECEPTOR LIGANDS 632
1,4-Dioxane, a Suitable Scaffold for the Development of Novel M3 Muscarinic Receptor Antagonists 629
1,4-Dioxane ring as a promising template of novel 5-HT1A full agonists 564
1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity 534
Roles of Wnt/β-catenin signalling pathway in the bony repair of injured growth plate cartilage in young rats 467
1,4-Dioxane Nucleus as a Suitable Scaffold for the Characterization of Different Receptor Systems 366
An Efficient Lewis Acid Catalyzed Povarov Reaction for the One-Pot Stereocontrolled Synthesis of Polyfunctionalized Tetrahydroquinolines 346
Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation 344
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 336
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor 331
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 330
Exploring the Role of N6‐Substituents in Potent Dual Acting 5'‐C‐Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice 321
Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring 310
TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation 306
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus 303
Novel triazolium based 11th group NHCs: synthesis, characterization and cellular response mechanisms 299
Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine 298
Combined Interactions with I1-, I2-Imidazoline Binding Sites and α2-Adrenoceptors To Manage Opioid Addiction 295
33rd camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 273
Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity 268
Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane 262
Investigation of allyphenyline efficacy in the treatment of alcohol withdrawal symptoms 258
Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancement. 254
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes 252
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 246
Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation 245
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease 244
Structure-Based Design, Synthesis and in vivo Antinociceptive Effects of Selective A1 Adenosine Receptor Agonists 240
Identification of 2-aminopyrimidine derivatives as inhibitors of the canonical Wnt signaling pathway 234
Biguanide derivatives as surfactants and antimicrobial agents for pharmaceutical applications 234
Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites 231
33rd Camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 225
Novel 1,4-dioxane derivatives as NMDA receptor channel blockers 224
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 221
From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: synthesis and biological evaluation of valproic esters of 3'-C-methyladenosine 220
77-LH-28-1 as a model for the rational design of selective dopamine D4 receptor ligands 220
Novel Highly Potent and Selective σ1 Receptor Antagonists Related to Spipethiane 218
Structure−Activity Relationships in 1,4-Benzodioxan-Related Compounds. 11.1 Reversed Enantioselectivity of 1,4-Dioxane Derivatives in α1‑Adrenergic and 5‑HT1A Receptor Binding Sites Recognition 217
Adenosine receptors as promising targets for the management of ocular diseases 217
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 213
Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide. 212
Design, Synthesis and Biological Evaluation of Novel Chemical Entities as Potential Anticancer Drugs and for the Control of the Metastatic Process 209
New insights in Au-NHCs complexes as anticancer agents 208
Low doses of allyphenyline and cyclomethyline, effective against morphine dependence, elicit an antidepressant-like effect 208
Might Adrenergic alpha2C-agonists/alpha2A-antagonists become novel therapeutic tools for pain treatment with morphine? 207
Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells 207
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders 205
Complessi di rame(I) con leganti tris(azolil)borati e fosfine monodentate: sintesi e studi biologici 205
Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation 203
28th Camerino-Cyprus-Noordwijkerhout Symposium - Trekking through Receptor Chemistry 201
4WD to Travel Inside the 5-HT1A Receptor World 201
BIOLOGICAL PROFILE AND BIOAVAILABILITY OF IMIDAZOLINE COMPOUNDS AFFECT THEIR MODULATORY ACTIVITY ON MORPHINE TOLERANCE 200
Synthesis and cytotoxic activity evaluation of new Cu(I) complexes of bis(pyrazol-1-yl) acetate ligands functionalized with an NMDA receptor antagonist 200
Enantioselective interactions to improve adrenergic α2C-agonism/α2A-antagonism 196
Synthesis of Triazole-Linked Analogues of c‐di-GMP and Their Interactions with Diguanylate Cyclase 196
Potent muscarinic antagonists bearing 1,4-dioxane scaffold 195
Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1‑[3- (4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77- LH-28-1) 195
Solution-phase synthesis of ICG-001, a beta-turn peptidomimetic molecule inhibitor of beta-catenin-Tcf-mediated transcription 194
Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity 194
Allyphenyline analogues potentially useful in the management of chronic pain and opioid addiction. 192
Rational design and biological evaluation of novel conjugated heteroscorpionate ligands and related Copper(I/II) complexes 192
Effects of imidazoline I2 receptor ligands on acute nociception in rats 191
NOVEL BIVALENT LIGANDS OF XANOMELINE AND 77-LH-28-1 AS POTENTIAL M1 MUSCARINIC AGONISTS 189
Novel Potent 5-HT1a Agonists Selective over alpha1-Adrenoceptor Subtypes 189
Front Cover, European Journal of Medicinal, Issue 146, 25 February 2018. 188
Dioxane and Oxathiane Nuclei: Suitable Substructures for Muscarinic Agonists 186
DOPAMINE D2, D3, AND D4 RECEPTOR AFFINITIES OF 77-LH-28-1 AND ITS ANALOGUES 186
Fruitful Adrenergic alpha(2C)-Agonism/alpha(2A)-Antagonism Combination to Prevent and Contrast Morphine Tolerance and Dependence 184
Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments 184
Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma 182
Novel highly potent and selective sigma1 receptor antagonists effectively block the binge eating episode in female rats 182
TESTING D2-LIKE RECEPTOR AFFINITY AND SELECTIVITY WITH NOVEL IMIDAZOLINE DERIVATIVES 180
Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior 179
Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor 179
Dual Alpha2C/5HT1A Receptor Agonist Allyphenyline Induces Gastroprotection and Inhibits Fundic and Colonic Contractility 177
The 2-substituted imidazoline ring linked to an aromatic moiety by a biatomic bridge: a bioversatile scaffold 176
Efficient Lewis Acid Systems for the A3 Coupling reaction 176
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9.From 1,4-benzodioxan to 1,4-dioxane ring as a promising template of novel alpha(1D)-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents. 175
Activation of primary amines by copper(I)-based Lewis acid promoters in the solventless synthesis of secondary propargylamines 175
MORPHINE TOLERANCE MODULATION INDUCED BY alpha2-ADRENERGIC OR/AND I2 IMIDAZOLINE BINDING SITES LIGANDS 174
Might adrenergic α2C-agonist/α2A-antagonist become a novel therapeutic multitarget tool for morphine chronic treatment of pain? 172
Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands 170
Imidazoline nucleus as a biologically versatile scaffold 168
From benzodioxane to 1,4-dioxane scaffold in the design of 5-HT1A serotoninergic full agonists from α1-adrenergic antagonists 166
Effects of allyphenyline on chronic alcohol intoxication model 162
Design, synthesis, reactivity, biological and catalytic applications of functionalized bis(pyrazolyl)acetate copper complexes 162
Hybrid molecules from xanomeline and 77-LH-28-1 as potential novel M1 muscarinic agonists 159
Trekking through receptor chemistry 156
Chemistry and antitumor investigations of new Cu(I) complexes of bis(pyrazol-1-yl)acetate ligands functionalized with an NMDA receptor antagonist 155
NOVEL IMIDAZOLINE MOLECULES INSPIRED BY THE PHARMACOLOGICAL PROFILE OF AGMATINE AS POTENTIAL TOOLS IN MANAGING OPIOID ADDICTION 154
A Versatile Continuous Fluorometric Enzymatic Assay for Targeting Nicotinate Phosphoribosyltransferase 152
Synthesis, reactivity and biological studies of bioconjugated bis(pyrazolyl)acetate copper complexes 147
Design and synthesis of novel imidazoline derivatives potentially targeting dopamine receptors 146
Molecular determinants in the binding of novel 1,4-benzodioxan-related α1D-adrenergic receptor antagonists: a computational study 145
Aminopyrimidines as inhibitors of the Wnt signalling pathway 144
Novel muscarinic antagonists designed on the 1,4-dioxane scaffold 141
Enantiomers of 6,6-diphenyl-1,4-dioxane derivatives to highlight stereochemical requirements for selective alpha1D-AR and 5- HT1A receptor recognition 140
New Arylpiperazines as Potent and Selective Dopamine D4 Receptor Ligands Potentially Useful to Treat Glioblastoma 139
Structural motives of imidazoline molecules favouring the serotonin 5-HT1A receptor activation 138
Totale 23.470
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.652
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.306 0 359 38 58 93 63 46 111 122 165 85 166
2022/20231.867 232 71 89 237 186 214 20 118 360 106 152 82
2023/20241.608 195 94 131 52 68 175 76 57 159 62 43 496
2024/20255.106 241 110 424 246 192 265 602 1.166 433 324 333 770
2025/20269.019 490 574 1.601 1.180 804 577 1.237 603 511 590 550 302
2026/2027951 710 241 0 0 0 0 0 0 0 0 0 0
Totale 29.671